138 related articles for article (PubMed ID: 9000570)
1. Inhibition of protein synthesis in small cell lung cancer cells induced by the diphtheria toxin-related fusion protein DAB389 GRP.
vanderSpek JC; Sutherland JA; Zeng H; Battey JF; Jensen RT; Murphy JR
Cancer Res; 1997 Jan; 57(2):290-4. PubMed ID: 9000570
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 7 (IL-7) receptor-specific cell killing by DAB389 IL-7: a novel agent for the elimination of IL-7 receptor positive cells.
Sweeney EB; Foss FM; Murphy JR; vanderSpek JC
Bioconjug Chem; 1998; 9(2):201-7. PubMed ID: 9548535
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 4 receptor targeted cytotoxicity: genetic construction and in vivo immunosuppressive activity of a diphtheria toxin-related murine interleukin 4 fusion protein.
Lakkis F; Steele A; Pacheco-Silva A; Rubin-Kelley V; Strom TB; Murphy JR
Eur J Immunol; 1991 Sep; 21(9):2253-8. PubMed ID: 1679715
[TBL] [Abstract][Full Text] [Related]
4. Targeting the epidermal growth factor receptor in breast cancer cell lines with a recombinant ligand fusion toxin (DAB389EGF).
Osborne CK; Coronado-Heinsohn E
Cancer J Sci Am; 1996; 2(3):175-80. PubMed ID: 9166518
[TBL] [Abstract][Full Text] [Related]
5. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
Zhou J; Chen J; Mokotoff M; Zhong R; Shultz LD; Ball ED
Clin Cancer Res; 2003 Oct; 9(13):4953-60. PubMed ID: 14581370
[TBL] [Abstract][Full Text] [Related]
6. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
[TBL] [Abstract][Full Text] [Related]
7. Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines.
Cardona C; Rabbitts PH; Spindel ER; Ghatei MA; Bleehen NM; Bloom SR; Reeve JG
Cancer Res; 1991 Oct; 51(19):5205-11. PubMed ID: 1717141
[TBL] [Abstract][Full Text] [Related]
8. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
Moody TW; Staley J; Zia F; Coy DH; Jensen RT
J Pharmacol Exp Ther; 1992 Oct; 263(1):311-7. PubMed ID: 1328611
[TBL] [Abstract][Full Text] [Related]
9. Effects of bombesin antagonists on the growth of small cell lung cancer cells in vitro.
Layton JE; Scanlon DB; Soveny C; Morstyn G
Cancer Res; 1988 Sep; 48(17):4783-9. PubMed ID: 2457430
[TBL] [Abstract][Full Text] [Related]
10. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
[TBL] [Abstract][Full Text] [Related]
11. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
Uchida K; Kojima A; Morokawa N; Tanabe O; Anzai C; Kawakami M; Eto Y; Yoshimura K
J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of AIDS-associated Kaposi's sarcoma cell growth by DAB389-interleukin 6.
Masood R; Lunardi-Iskandar Y; Jean LF; Murphy JR; Waters C; Gallo RC; Gill P
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):969-75. PubMed ID: 7811548
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of human myeloma cell lines and normal bone marrow colony forming cells to a recombinant diphtheria toxin-interleukin 6 fusion protein.
Chadwick DE; Jean LF; Jamal N; Messner HA; Murphy JR; Minden MD
Br J Haematol; 1993 Sep; 85(1):25-36. PubMed ID: 8251407
[TBL] [Abstract][Full Text] [Related]
14. The Ewing tumor family of peripheral primitive neuroectodermal tumors expresses human gastrin-releasing peptide.
Lawlor ER; Lim JF; Tao W; Poremba C; Chow CJ; Kalousek IV; Kovar H; MacDonald TJ; Sorensen PH
Cancer Res; 1998 Jun; 58(11):2469-76. PubMed ID: 9622091
[TBL] [Abstract][Full Text] [Related]
15. Nonconstitutive expression of the gastrin-releasing peptide autocrine growth system in human small cell lung carcinoma NCI-H345 cells.
Aguayo SM; Miller Y; Boose D; Holley M; Portanova LB; Schuyler KD; Kane MA
Cell Growth Differ; 1996 May; 7(5):563-72. PubMed ID: 8732666
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxic profile of a diphtheria toxin-neurotrophin-4 chimera.
Negro A; Skaper SD
J Neurochem; 1997 Feb; 68(2):554-63. PubMed ID: 9003040
[TBL] [Abstract][Full Text] [Related]
17. Gastrin-releasing peptide receptor signaling resulting in growth inhibition.
Feldman RI; Fried S; Mann E; Wu JM; Liang M
Mol Pharmacol; 1996 Mar; 49(3):505-14. PubMed ID: 8643090
[TBL] [Abstract][Full Text] [Related]
18. [Construction and expression of the fusion protein DT389-hIL-13 and its cytotoxicity to glioma cell lines].
Tuo HZ; Wang JW; Wang DX; Li JM; Ouyang J; Hong T
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1024-8. PubMed ID: 15312540
[TBL] [Abstract][Full Text] [Related]
19. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
Zhou J; Chen J; Zhong R; Mokotoff M; Shultz LD; Ball ED
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2224-31. PubMed ID: 16609038
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation and DNase I hypersensitive sites are associated with selective expression of the gastrin-releasing peptide gene.
Markowitz S; Krystal G; Lebacq-Verheyden AM; Way J; Sausville EA; Battey J
J Clin Invest; 1988 Sep; 82(3):808-15. PubMed ID: 2843572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]